FNCH
Finch Therapeutics Group Inc
Price Chart
No historical data available
Latest Quote
$9.20
+0.00 (+0.00%)
Current Price
| Previous Close | $9.20 |
| Open | $11.90 |
| Day High | $11.91 |
| Day Low | $5.01 |
| Volume | 71,791 |
Stock Information
| Shares Outstanding | 1.61M |
| Total Debt | $28.99M |
| Cash Equivalents | $16.04M |
| Net Income | $-14.17M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $14.77M |
| EPS (TTM) | $-8.80 |
| Exchange | PNK |
Recent Price History
No history data available. Data will be fetched automatically.
About Finch Therapeutics Group Inc
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524 for the prevention, diagnosis, theragnosis or treatment of diseases in humans, including ulcerative colitis; FIN-525 for the treatment of Crohn's disease; and other microbiome product candidates. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; and license agreements with Skysong Innovations LLC, OpenBiome, Arizona State University, and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Boston, Massachusetts. On March 22, 2026, Finch Therapeutics Group, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Period:
Loading...
Income Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Revenue | |||
| Total Revenue | $107,000 | $861,000 | $18,532,000 |
| Operating Revenue | $107,000 | $861,000 | $18,532,000 |
| Expenses | |||
| Total Expenses | $34,109,000 | $89,055,000 | $78,517,000 |
| Other Income Expense | $-45,783,000 | $-26,704,000 | $1,803,000 |
| Other Non Operating Income Expenses | $4,053,000 | $702,000 | $-52,000 |
| Net Non Operating Interest Income Expense | $1,570,000 | $252,000 | $22,000 |
| Operating Expense | $34,109,000 | $89,055,000 | $78,517,000 |
| General And Administrative Expense | $26,910,000 | $36,192,000 | $21,238,000 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-74,754,000 | $-114,646,000 | $-58,160,000 |
| Net Interest Income | $1,570,000 | $252,000 | $22,000 |
| Interest Income | $1,570,000 | $252,000 | $22,000 |
| Normalized Income | $-27,130,718 | $-87,240,000 | $-60,015,000 |
| Net Income From Continuing And Discontinued Operation | $-74,754,000 | $-114,646,000 | $-58,160,000 |
| Total Operating Income As Reported | $-83,861,000 | $-115,593,000 | $-59,985,000 |
| Net Income Common Stockholders | $-74,754,000 | $-114,646,000 | $-58,160,000 |
| Net Income | $-74,754,000 | $-114,646,000 | $-58,160,000 |
| Net Income Including Noncontrolling Interests | $-74,754,000 | $-114,646,000 | $-58,160,000 |
| Net Income Continuous Operations | $-74,754,000 | $-114,646,000 | $-58,160,000 |
| Pretax Income | $-78,215,000 | $-114,646,000 | $-58,160,000 |
| Special Income Charges | $-49,836,000 | $-27,406,000 | $1,855,000 |
| Interest Income Non Operating | $1,570,000 | $252,000 | $22,000 |
| Operating Income | $-34,002,000 | $-88,194,000 | $-59,985,000 |
| Per Share | |||
| Diluted EPS | $-46.59 | $-72.00 | $-44.40 |
| Basic EPS | $-46.59 | $-72.00 | $-44.40 |
| Other | |||
| Tax Effect Of Unusual Items | $-2,212,718 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $17,354,000 | $-55,281,000 | $-59,539,000 |
| Total Unusual Items | $-49,836,000 | $-27,406,000 | $1,855,000 |
| Total Unusual Items Excluding Goodwill | $-49,836,000 | $-27,406,000 | $1,855,000 |
| Reconciled Depreciation | $1,520,000 | $5,507,000 | $2,301,000 |
| EBITDA (Bullshit earnings) | $-32,482,000 | $-82,687,000 | $-57,684,000 |
| EBIT | $-34,002,000 | $-88,194,000 | $-59,985,000 |
| Diluted Average Shares | $1,604,549 | $1,589,721 | $1,306,736 |
| Basic Average Shares | $1,604,549 | $1,589,721 | $1,306,736 |
| Diluted NI Availto Com Stockholders | $-74,754,000 | $-114,646,000 | $-58,160,000 |
| Tax Provision | $-3,461,000 | $0 | $0 |
| Gain On Sale Of Ppe | $637,000 | $-7,000 | $28,000 |
| Other Special Charges | $614,000 | - | $-1,827,000 |
| Impairment Of Capital Assets | $46,041,000 | $24,983,000 | $0 |
| Restructuring And Mergern Acquisition | $3,818,000 | $2,416,000 | $0 |
| Research And Development | $7,199,000 | $52,863,000 | $57,279,000 |
| Selling General And Administration | $26,910,000 | $36,192,000 | $21,238,000 |
| Other Gand A | $23,253,000 | $24,223,000 | $9,509,000 |
| Salaries And Wages | $3,657,000 | $11,969,000 | $11,729,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $22,886,000 | $62,811,000 | $151,267,000 |
| Total Assets | $55,373,000 | $162,939,000 | $225,369,000 |
| Total Non Current Assets | $29,526,000 | $88,388,000 | $82,818,000 |
| Other Non Current Assets | $2,348,000 | $6,800,000 | $7,173,000 |
| Goodwill And Other Intangible Assets | $0 | $32,900,000 | $50,957,000 |
| Current Assets | $25,847,000 | $74,551,000 | $142,551,000 |
| Other Current Assets | $723,000 | $3,369,000 | $8,576,000 |
| Receivables | $0 | $144,000 | $494,000 |
| Accounts Receivable | $0 | $144,000 | $494,000 |
| Cash Cash Equivalents And Short Term Investments | $25,124,000 | $71,038,000 | $133,481,000 |
| Cash And Cash Equivalents | $25,124,000 | $71,038,000 | $133,481,000 |
| Other Intangible Assets | - | $32,900,000 | $32,900,000 |
| Non Current Deferred Assets | - | - | $0 |
| Prepaid Assets | - | - | $8,576,000 |
| Debt | |||
| Total Debt | $30,126,000 | $52,339,000 | $6,015,000 |
| Long Term Debt And Capital Lease Obligation | $28,403,000 | $48,908,000 | $4,887,000 |
| Current Debt And Capital Lease Obligation | $1,723,000 | $3,431,000 | $1,128,000 |
| Long Term Debt | - | $14,653,000 | - |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $32,487,000 | $67,228,000 | $23,145,000 |
| Total Non Current Liabilities Net Minority Interest | $28,403,000 | $52,539,000 | $8,355,000 |
| Non Current Deferred Liabilities | $0 | $3,461,000 | $3,461,000 |
| Non Current Deferred Taxes Liabilities | $0 | $3,461,000 | $3,461,000 |
| Current Liabilities | $4,084,000 | $14,689,000 | $14,790,000 |
| Payables And Accrued Expenses | $2,236,000 | $10,578,000 | $9,261,000 |
| Payables | $559,000 | $1,965,000 | $3,737,000 |
| Total Tax Payable | $418,000 | $868,000 | - |
| Accounts Payable | $141,000 | $1,097,000 | $3,737,000 |
| Other Non Current Liabilities | - | $170,000 | $7,000 |
| Current Deferred Liabilities | - | - | $0 |
| Equity | |||
| Common Stock Equity | $22,886,000 | $95,711,000 | $202,224,000 |
| Total Equity Gross Minority Interest | $22,886,000 | $95,711,000 | $202,224,000 |
| Stockholders Equity | $22,886,000 | $95,711,000 | $202,224,000 |
| Retained Earnings | $-350,395,000 | $-275,641,000 | $-160,995,000 |
| Preferred Securities Outside Stock Equity | $0 | $0 | $0 |
| Other | |||
| Ordinary Shares Number | $1,605,763 | $1,601,786 | $1,583,739 |
| Share Issued | $1,605,763 | $1,601,786 | $1,583,739 |
| Tangible Book Value | $22,886,000 | $62,811,000 | $151,267,000 |
| Invested Capital | $22,886,000 | $110,364,000 | $202,224,000 |
| Working Capital | $21,763,000 | $59,862,000 | $127,761,000 |
| Capital Lease Obligations | $30,126,000 | $37,686,000 | $6,015,000 |
| Total Capitalization | $22,886,000 | $110,364,000 | $202,224,000 |
| Additional Paid In Capital | $373,279,000 | $371,350,000 | $363,172,000 |
| Capital Stock | $2,000 | $2,000 | $47,000 |
| Common Stock | $2,000 | $2,000 | $47,000 |
| Long Term Capital Lease Obligation | $28,403,000 | $34,255,000 | $4,887,000 |
| Current Capital Lease Obligation | $1,723,000 | $3,431,000 | $1,128,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $125,000 | $680,000 | $4,401,000 |
| Current Accrued Expenses | $1,677,000 | $8,613,000 | $5,524,000 |
| Net PPE | $27,178,000 | $48,688,000 | $24,688,000 |
| Accumulated Depreciation | $-275,000 | $-9,286,000 | $-4,226,000 |
| Gross PPE | $27,453,000 | $57,974,000 | $28,914,000 |
| Leases | $0 | $13,972,000 | $13,894,000 |
| Construction In Progress | $0 | $316,000 | $329,000 |
| Other Properties | $26,584,000 | $36,898,000 | $8,903,000 |
| Machinery Furniture Equipment | $869,000 | $6,788,000 | $5,788,000 |
| Properties | $0 | $0 | $0 |
| Goodwill | - | $0 | $18,057,000 |
| Non Current Deferred Revenue | - | - | $0 |
| Current Deferred Revenue | - | - | $0 |
| Dueto Related Parties Current | - | - | $0 |
| Duefrom Related Parties Current | - | - | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-31,505,000 | $-77,033,000 | $-83,116,000 |
| Operating Activities | |||
| Operating Cash Flow | $-31,505,000 | $-74,851,000 | $-67,133,000 |
| Cash Flow From Continuing Operating Activities | $-31,505,000 | $-74,851,000 | $-67,133,000 |
| Operating Gains Losses | $729,000 | $7,000 | $-1,836,000 |
| Investing Activities | |||
| Investing Cash Flow | $1,327,000 | $-2,182,000 | $-15,921,000 |
| Cash Flow From Continuing Investing Activities | $1,327,000 | $-2,182,000 | $-15,921,000 |
| Capital Expenditure | - | $-2,182,000 | $-15,983,000 |
| Financing Activities | |||
| Financing Cash Flow | $-16,155,000 | $14,873,000 | $119,110,000 |
| Cash Flow From Continuing Financing Activities | $-16,155,000 | $14,873,000 | $119,110,000 |
| Issuance Of Capital Stock | - | $0 | $118,576,000 |
| Net Other Financing Charges | - | $-132,000 | $-2,659,000 |
| Net Common Stock Issuance | - | $0 | $118,576,000 |
| Common Stock Issuance | - | $0 | $118,576,000 |
| Net Preferred Stock Issuance | - | - | $0 |
| Preferred Stock Issuance | - | - | $0 |
| Other | |||
| Repayment Of Debt | $-16,155,000 | $-22,000 | $-27,000 |
| Issuance Of Debt | $0 | $14,738,000 | $0 |
| Interest Paid Supplemental Data | $202,000 | $741,000 | $9,000 |
| End Cash Position | $27,472,000 | $73,805,000 | $135,965,000 |
| Beginning Cash Position | $73,805,000 | $135,965,000 | $99,909,000 |
| Changes In Cash | $-46,333,000 | $-62,160,000 | $36,056,000 |
| Proceeds From Stock Option Exercised | $0 | $289,000 | $3,220,000 |
| Net Issuance Payments Of Debt | $-16,155,000 | $14,716,000 | $-27,000 |
| Net Long Term Debt Issuance | $-16,155,000 | $14,716,000 | $-27,000 |
| Long Term Debt Payments | $-16,155,000 | $-22,000 | $-27,000 |
| Long Term Debt Issuance | $0 | $14,738,000 | $0 |
| Net PPE Purchase And Sale | $1,327,000 | $-2,182,000 | $-15,921,000 |
| Sale Of PPE | $1,327,000 | $0 | $62,000 |
| Purchase Of PPE | $0 | $-2,182,000 | $-15,983,000 |
| Change In Working Capital | $-5,420,000 | $-1,564,000 | $-14,512,000 |
| Change In Other Current Liabilities | $-2,932,000 | $1,981,000 | $-1,006,000 |
| Change In Other Current Assets | $4,033,000 | $656,000 | $-4,689,000 |
| Change In Payables And Accrued Expense | $-8,785,000 | $-2,022,000 | $7,430,000 |
| Change In Accrued Expense | $-7,829,000 | $237,000 | $5,435,000 |
| Change In Payable | $-956,000 | $-2,259,000 | $1,995,000 |
| Change In Account Payable | $-956,000 | $-2,259,000 | $2,261,000 |
| Change In Prepaid Assets | $2,121,000 | $-2,529,000 | $-3,217,000 |
| Change In Receivables | $143,000 | $350,000 | $601,000 |
| Changes In Account Receivables | $143,000 | $350,000 | $540,000 |
| Other Non Cash Items | $1,911,000 | $3,018,000 | $913,000 |
| Stock Based Compensation | $1,929,000 | $7,844,000 | $4,161,000 |
| Asset Impairment Charge | $46,041,000 | $24,983,000 | $0 |
| Deferred Tax | $-3,461,000 | $0 | - |
| Deferred Income Tax | $-3,461,000 | $0 | - |
| Depreciation Amortization Depletion | $1,520,000 | $5,507,000 | $2,301,000 |
| Depreciation And Amortization | $1,520,000 | $5,507,000 | $2,301,000 |
| Gain Loss On Sale Of PPE | $-637,000 | $7,000 | $-28,000 |
| Net Income From Continuing Operations | $-74,754,000 | $-114,646,000 | $-58,160,000 |
| Change In Other Working Capital | - | - | $-13,631,000 |
Fetched: 2026-02-02